RBC Capital Reiterates Outperform on AdaptHealth, Maintains $13 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix has reiterated an Outperform rating on AdaptHealth (NASDAQ:AHCO) and maintained a $13 price target.
August 12, 2024 | 2:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Ben Hendrix has reiterated an Outperform rating on AdaptHealth (NASDAQ:AHCO) and maintained a $13 price target.
The reiteration of an Outperform rating and the maintenance of a $13 price target by RBC Capital is a positive signal for investors, suggesting confidence in the company's future performance. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100